"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."

Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

News

 

 

Terumo Invests 26 Million Euro in New Production Lines for its Belgian Facilityhttps://www.terumo-europe.com/en-emea/news/terumo-invests-26-million-euro-in-new-production-lines-for-its-belgian-facilityTerumo Invests 26 Million Euro in New Production Lines for its Belgian FacilityLeuven, Belgium7/7/2019 10:00:00 PM<p style="text-align:justify;">Terumo Corporation (TSE: 4543), a leading global medical device manufacturer, today announced an investment of 26 million euro in the production facility of Terumo Europe in Leuven (Belgium), where Terumo produces and assembles medical devices. Terumo extends its production capacity at Terumo Europe to meet the growing demand for Terumo products. The new production lines will be operational within two to three years. Terumo Europe employs approximately 1,300 people in the EMEA region.</p>
Terumo Enhances Coronary Interventional Product Portfolio by Securing Exclusive Global Rightshttps://www.terumo-europe.com/en-emea/news/terumo-enhances-coronary-interventional-product-portfolio-by-securing-exclusive-global-rightsTerumo Enhances Coronary Interventional Product Portfolio by Securing Exclusive Global RightsTokyo, Japan6/12/2019 10:00:00 PM<p>​​To Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership. First and only non-coated drug-eluting angioplasty balloon that delivers a proprietary bioabsorbable, sustained-release formulation of sirolimus.<br></p>
Terumo Establishes New Group Identity Institutes "Core Values" to be Shared by All Associateshttps://www.terumo-europe.com/en-emea/news/terumo-establishes-new-group-identity-institutes-core-values-to-be-shared-by-all-associatesTerumo Establishes New Group Identity Institutes "Core Values" to be Shared by All AssociatesTokyo, Japan3/31/2019 10:00:00 PM
Terumo Pharmaceutical Solutions wins 2019 Asia-Pacific Industry Awardhttps://www.terumo-europe.com/en-emea/news/terumo-pharmaceutical-solutions-wins-asia-pacific-industry-awardTerumo Pharmaceutical Solutions wins 2019 Asia-Pacific Industry AwardTokyo, Japan2/27/2019 11:00:00 PM
Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox® Oxygenatorhttps://www.terumo-europe.com/en-emea/news/terumo-introduces-its-smallest-lowest-prime-volume-full-size-adult-capiox®-oxygenatorTerumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox® OxygenatorAnn Arbor, MICH.1/16/2019 11:00:00 PM<p>​<span>Innovative technology improves patient care during cardiopulmonary bypass</span></p>